First Horizon Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15
| Closed | -$1.06K | – | 2346 |
|
|
2025
Q1 | $1.06K | Hold |
15
| – | – | ﹤0.01% | 2119 |
|
|
2024
Q4 | $986 | Sell |
15
-89
| -86% | -$5.85K | ﹤0.01% | 2099 |
|
|
2024
Q3 | $7.31K | Sell |
104
-472
| -82% | -$33.2K | ﹤0.01% | 1708 |
|
|
2024
Q2 | $47.4K | Hold |
576
| – | – | ﹤0.01% | 942 |
|
|
2024
Q1 | $50.3K | Hold |
576
| – | – | ﹤0.01% | 939 |
|
|
2023
Q4 | $55.5K | Buy |
576
+144
| +33% | +$13.9K | ﹤0.01% | 888 |
|
|
2023
Q3 | $38.2K | Hold |
432
| – | – | ﹤0.01% | 969 |
|
|
2023
Q2 | $37.4K | Sell |
432
-79
| -15% | -$6.85K | ﹤0.01% | 1015 |
|
|
2023
Q1 | $49.7K | Hold |
511
| – | – | ﹤0.01% | 878 |
|
|
2022
Q4 | $52.9K | Buy |
511
+15
| +3% | +$1.55K | ﹤0.01% | 835 |
|
|
2022
Q3 | $41K | Sell |
496
-39
| -7% | -$3.22K | ﹤0.01% | 910 |
|
|
2022
Q2 | $43K | Buy |
535
+487
| +1,015% | +$39.1K | ﹤0.01% | 983 |
|
|
2022
Q1 | $4K | Sell |
48
-206
| -81% | -$17.2K | ﹤0.01% | 1324 |
|
|
2021
Q4 | $22K | Buy |
254
+2
| +0.8% | +$173 | ﹤0.01% | 1232 |
|
|
2021
Q3 | $19K | Sell |
252
-409
| -62% | -$30.8K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $54K | Sell |
661
-56
| -8% | -$4.58K | ﹤0.01% | 748 |
|
|
2021
Q1 | $53K | Buy |
717
+61
| +9% | +$4.51K | ﹤0.01% | 716 |
|
|
2020
Q4 | $57K | Buy |
656
+204
| +45% | +$17.7K | ﹤0.01% | 556 |
|
|
2020
Q3 | $33K | Buy |
452
+60
| +15% | +$4.38K | ﹤0.01% | 656 |
|
|
2020
Q2 | $47K | Hold |
392
| – | – | ﹤0.01% | 538 |
|
|
2020
Q1 | $32K | Buy |
392
+59
| +18% | +$4.82K | ﹤0.01% | 576 |
|
|
2019
Q4 | $27K | Hold |
333
| – | – | ﹤0.01% | 753 |
|
|
2019
Q3 | $21K | Buy |
333
+302
| +974% | +$19K | ﹤0.01% | 823 |
|
|
2019
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 1379 |
|
|
2019
Q1 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 1400 |
|
|
2018
Q4 | – | Sell |
-7
| Closed | – | – | 1505 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 1533 |
|
|
2018
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 1540 |
|